United Health Products, Inc., a company based in Cocoa, Colorado, operates within the health care equipment and supplies sector. As a distributor of health care products, the company holds worldwide distribution rights to a range of gauze bandages, positioning itself as a key player in the medical supplies market. The company’s operations are primarily focused on providing essential health care products to a global audience, leveraging its distribution rights to maintain a competitive edge.
As of March 24, 2026, United Health Products, Inc. was trading on the OTC Bulletin Board, a platform for smaller companies not listed on major exchanges. The company’s stock closed at $0.044, reflecting a significant decrease from its 52-week high of $0.285, recorded on April 1, 2025. Conversely, the stock reached its 52-week low of $0.04 on November 9, 2025, indicating a period of volatility in its market performance.
The company’s market capitalization stands at approximately $12,675,822 USD, which provides insight into its valuation within the health care equipment and supplies industry. Despite its strategic position in the market, United Health Products, Inc. has a negative price-to-earnings (P/E) ratio of -3.767. This negative P/E ratio suggests that the company is currently not generating profits, which could be a point of concern for investors evaluating its financial health and future growth prospects.
United Health Products, Inc. continues to focus on its core business of distributing gauze bandages and other health care supplies. For more detailed information about their product offerings and services, stakeholders and interested parties are encouraged to visit their official website at www.unitedecoenergy.com . This platform serves as a resource for potential customers and partners seeking to engage with the company’s products and distribution capabilities.
In summary, United Health Products, Inc. remains a notable entity within the health care equipment and supplies sector, despite facing challenges reflected in its stock performance and financial metrics. The company’s strategic distribution rights and focus on essential health care products continue to define its market presence.
